Clinical Trial Update: To Evaluate the Safety, Tolerability and Analgesic Efficacy of SAF312 in Postoperative Dental Pain Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating SAF312 for safety, tolerability, and analgesic efficacy in postoperative dental pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• SAF312

Snippet

Sponsor: Novartis | Conditions: Postoperative Pain | Phase 2 | Status: COMPLETED